|
IL13RA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.808400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.613800E-01 |
| Normal-vs-Stage2 |
4.569800E-01 |
| Normal-vs-Stage3 |
2.751400E-01 |
| Normal-vs-Stage4 |
6.144600E-01 |
| Stage1-vs-Stage2 |
8.351800E-01 |
| Stage1-vs-Stage3 |
6.805600E-01 |
| Stage1-vs-Stage4 |
9.106200E-01 |
| Stage2-vs-Stage3 |
9.547800E-01 |
| Stage2-vs-Stage4 |
8.106600E-01 |
| Stage3-vs-Stage4 |
7.177600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.724640E-01 |
| Normal-vs-AfricanAmerican |
1.545010E-01 |
| Normal-vs-Asian |
1.110620E-01 |
| Caucasian-vs-AfricanAmerican |
1.239880E-02 |
| Caucasian-vs-Asian |
3.186800E-01 |
| AfricanAmerican-vs-Asian |
3.609600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.417010E-01 |
| Normal-vs-Female |
8.695200E-01 |
| Male-vs-Female |
8.564200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.862800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.215000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.339800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.710800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.984040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.931030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.058200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.920800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.523400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.874200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.751400E-01 |
| Normal-vs-Grade 2 |
1.482430E-01 |
| Normal-vs-Grade 3 |
5.701000E-01 |
| Normal-vs-Grade 4 |
3.591400E-01 |
| Grade 1-vs-Grade 2 |
5.521200E-01 |
| Grade 1-vs-Grade 3 |
8.020600E-01 |
| Grade 1-vs-Grade 4 |
4.909800E-01 |
| Grade 2-vs-Grade 3 |
2.802000E-01 |
| Grade 2-vs-Grade 4 |
9.666400E-01 |
| Grade 3-vs-Grade 4 |
5.652400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.852600E-01 |
| Normal-vs-ccB subtype |
2.747600E-02 |
| ccA subtype-vs-ccB subtype |
5.421700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.672450E-01 |
| Normal-vs-N1 |
2.987400E-01 |
| N0-vs-N1 |
5.048400E-01 |
|
|
